Benzinga | Nov 6, 2020 06:12AM EST

Amneal Pharmaceuticals Q3 Adj. EPS $0.16 Beats $0.12 Estimate, Sales $519.29M Beat $482.11M Estimate

Amneal Pharmaceuticals (NYSE:AMRX) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.12 by 33.33 percent. This is a 300 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $519.29 million which beat the analyst consensus estimate of $482.11 million by 7.71 percent. This is a 37.28 percent increase over sales of $378.28 million the same period last year.